Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children

Clinical trial NCT01430611 · COMPLETED

Trial details

NCT number: NCT01430611
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Meningococcal Disease Meningitis

Start date: 2011-08-01
Primary completion: 2012-08-01
Enrollment: 666

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.